CEL-SCI Corp (CVM)
1.64
+0.16
(+10.81%)
USD |
NYAM |
May 03, 16:00
1.64
0.00 (0.00%)
After-Hours: 20:00
CEL-SCI Accounts Payable (Quarterly): 1.144M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.144M |
September 30, 2023 | 2.010M |
June 30, 2023 | 1.743M |
March 31, 2023 | 1.889M |
December 31, 2022 | 1.600M |
September 30, 2022 | 1.618M |
June 30, 2022 | 0.8529M |
March 31, 2022 | 1.316M |
December 31, 2021 | 1.193M |
September 30, 2021 | 1.676M |
June 30, 2021 | 2.144M |
March 31, 2021 | 2.391M |
December 31, 2020 | 3.093M |
September 30, 2020 | 2.023M |
June 30, 2020 | 0.9438M |
March 31, 2020 | 1.140M |
December 31, 2019 | 1.439M |
September 30, 2019 | 1.586M |
June 30, 2019 | 2.079M |
March 31, 2019 | 4.159M |
December 31, 2018 | 4.903M |
September 30, 2018 | 5.744M |
June 30, 2018 | 6.254M |
March 31, 2018 | 7.687M |
December 31, 2017 | 7.873M |
Date | Value |
---|---|
September 30, 2017 | 8.196M |
June 30, 2017 | 8.352M |
March 31, 2017 | 7.075M |
December 31, 2016 | 2.741M |
September 30, 2016 | 3.092M |
June 30, 2016 | 4.437M |
March 31, 2016 | 3.770M |
December 31, 2015 | 3.856M |
September 30, 2015 | 5.129M |
June 30, 2015 | 3.158M |
March 31, 2015 | 1.704M |
December 31, 2014 | 1.642M |
September 30, 2014 | 1.161M |
June 30, 2014 | 1.364M |
March 31, 2014 | 1.346M |
December 31, 2013 | 1.628M |
September 30, 2013 | 1.924M |
June 30, 2013 | 1.176M |
March 31, 2013 | 0.4658M |
December 31, 2012 | 0.4103M |
September 30, 2012 | 0.5929M |
June 30, 2012 | 0.7027M |
March 31, 2012 | 0.7081M |
December 31, 2011 | 0.6319M |
September 30, 2011 | 0.739M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.8529M
Minimum
Jun 2022
3.093M
Maximum
Dec 2020
1.678M
Average
1.618M
Median
Sep 2022
Accounts Payable (Quarterly) Benchmarks
Synlogic Inc | 1.457M |
BioXcel Therapeutics Inc | 13.65M |
IGM Biosciences Inc | 1.326M |
Intelligent Bio Solutions Inc | 1.763M |
Syra Health Corp | 0.463M |